Skincare giant Beiersdorf is doubling down on artificial intelligence (AI).
The German-based company, which owns the brands Nivea, Eucerin and La Prairie, has partnered with the AI business Insilico Medicine – which develops end-to-end drug discovery pipelines – to carry out computer-simulated skin research. The duo will explore "novel, safe bioactive ingredients", with Beiersdorf aiming to use the findings as a basis for eventual skincare product development.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!